-
Something wrong with this record ?
Impaired lung function and mortality in Eastern Europe: results from multi-centre cohort study
T. Sarycheva, N. Capkova, A. Pająk, S. Malyutina, G. Simonova, A. Tamosiunas, M. Bobák, H. Pikhart
Language English Country Great Britain
Document type Journal Article, Multicenter Study
NLK
BioMedCentral
from 2000-04-01
BioMedCentral Open Access
from 2000
Directory of Open Access Journals
from 2000
Free Medical Journals
from 2000
PubMed Central
from 2000
Europe PubMed Central
from 2000
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2000-01-01
Open Access Digital Library
from 2000-01-01
Open Access Digital Library
from 2000-06-01
Medline Complete (EBSCOhost)
from 2000-01-01
Health & Medicine (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2000
Springer Nature OA/Free Journals
from 2000-04-01
- MeSH
- Cardiovascular Diseases * epidemiology MeSH
- Cohort Studies MeSH
- Humans MeSH
- Lung MeSH
- Prospective Studies MeSH
- Risk Factors MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
- Geographicals
- Poland MeSH
BACKGROUND: The association between impaired lung function and mortality has been well documented in the general population of Western European countries. We assessed the risk of death associated with reduced spirometry indices among people from four Central and Eastern European countries. METHODS: This prospective population-based cohort includes men and women aged 45-69 years, residents in urban settlements in Czech Republic, Poland, Russia and Lithuania, randomly selected from population registers. The baseline survey in 2002-2005 included 36,106 persons of whom 24,993 met the inclusion criteria. Cox proportional hazards models were used to estimate the hazard ratios of mortality over 11-16 years of follow-up for mild, moderate, moderate-severe and very severe lung function impairment categories. RESULTS: After adjusting for covariates, mild (hazard ratio (HR): 1.25; 95% CI 1.15‒1.37) to severe (HR: 3.35; 95% CI 2.62‒4.27) reduction in FEV1 was associated with an increased risk of death according to degree of lung impairment, compared to people with normal lung function. The association was only slightly attenuated but remained significant after exclusion of smokers and participants with previous history of respiratory diseases. The HRs varied between countries but not statistically significant; the highest excess risk among persons with more severe impairment was seen in Poland (HR: 4.28, 95% CI 2.14‒8.56) and Lithuania (HR: 4.07, 95% CI 2.21‒7.50). CONCLUSIONS: Reduced FEV1 is an independent predictor of all-cause mortality, with risk increasing with the degree of lung function impairment and some country-specific variation between the cohorts.
National Institute of Public Health Prague Czech Republic
Novosibirsk State Medical University Novosibirsk Russia
Research Department of Epidemiology and Public Health University College London London UK
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22018289
- 003
- CZ-PrNML
- 005
- 20220804134658.0
- 007
- ta
- 008
- 220720s2022 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12931-022-02057-y $2 doi
- 035 __
- $a (PubMed)35641974
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Sarycheva, Tatyana $u Research Centre for Toxic Compounds in the Environment (RECETOX), Faculty of Science, Masaryk University, Koltarska 2, 611 37, Brno, Czech Republic. tatyana.sarycheva@recetox.muni.cz
- 245 10
- $a Impaired lung function and mortality in Eastern Europe: results from multi-centre cohort study / $c T. Sarycheva, N. Capkova, A. Pająk, S. Malyutina, G. Simonova, A. Tamosiunas, M. Bobák, H. Pikhart
- 520 9_
- $a BACKGROUND: The association between impaired lung function and mortality has been well documented in the general population of Western European countries. We assessed the risk of death associated with reduced spirometry indices among people from four Central and Eastern European countries. METHODS: This prospective population-based cohort includes men and women aged 45-69 years, residents in urban settlements in Czech Republic, Poland, Russia and Lithuania, randomly selected from population registers. The baseline survey in 2002-2005 included 36,106 persons of whom 24,993 met the inclusion criteria. Cox proportional hazards models were used to estimate the hazard ratios of mortality over 11-16 years of follow-up for mild, moderate, moderate-severe and very severe lung function impairment categories. RESULTS: After adjusting for covariates, mild (hazard ratio (HR): 1.25; 95% CI 1.15‒1.37) to severe (HR: 3.35; 95% CI 2.62‒4.27) reduction in FEV1 was associated with an increased risk of death according to degree of lung impairment, compared to people with normal lung function. The association was only slightly attenuated but remained significant after exclusion of smokers and participants with previous history of respiratory diseases. The HRs varied between countries but not statistically significant; the highest excess risk among persons with more severe impairment was seen in Poland (HR: 4.28, 95% CI 2.14‒8.56) and Lithuania (HR: 4.07, 95% CI 2.21‒7.50). CONCLUSIONS: Reduced FEV1 is an independent predictor of all-cause mortality, with risk increasing with the degree of lung function impairment and some country-specific variation between the cohorts.
- 650 12
- $a kardiovaskulární nemoci $x epidemiologie $7 D002318
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a plíce $7 D008168
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a rizikové faktory $7 D012307
- 651 _2
- $a Polsko $x epidemiologie $7 D011044
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 700 1_
- $a Capkova, Nadezda $u National Institute of Public Health, Prague, Czech Republic
- 700 1_
- $a Pająk, Andrzej $u Department of Epidemiology and Population Sciences, Institute of Public Health, Jagiellonian University Medical College, Kraków, Poland
- 700 1_
- $a Malyutina, Sofia $u Research Institute of Internal and Preventive Medicine - Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russia $u Novosibirsk State Medical University, Novosibirsk, Russia
- 700 1_
- $a Simonova, Galina $u Research Institute of Internal and Preventive Medicine - Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russia
- 700 1_
- $a Tamosiunas, Abdonas $u Laboratory of Population Research, Institute of Cardiology, Lithuanian University of Health Sciences, Kaunas, Lithuania
- 700 1_
- $a Bobák, Martin $u Research Centre for Toxic Compounds in the Environment (RECETOX), Faculty of Science, Masaryk University, Koltarska 2, 611 37, Brno, Czech Republic $u Research Department of Epidemiology and Public Health, University College London, London, UK
- 700 1_
- $a Pikhart, Hynek $u Research Centre for Toxic Compounds in the Environment (RECETOX), Faculty of Science, Masaryk University, Koltarska 2, 611 37, Brno, Czech Republic $u Research Department of Epidemiology and Public Health, University College London, London, UK
- 773 0_
- $w MED00006600 $t Respiratory research $x 1465-993X $g Roč. 23, č. 1 (2022), s. 140
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35641974 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804134652 $b ABA008
- 999 __
- $a ok $b bmc $g 1822067 $s 1169532
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 23 $c 1 $d 140 $e 20220531 $i 1465-993X $m Respiratory research $n Respir Res $x MED00006600
- LZP __
- $a Pubmed-20220720